Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000919574-25-004068·Jasper Therapeutics, Inc.
Schedule 13G ownership disclosure
JASPER THERAPEUTICS INC
Voting Common Stock, par value $0.0001 per share · CUSIP: 471871202
Event date: 2025-07-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- KINGDON CAPITAL MANAGEMENT, L.L.C.
Shares: 765,000.00 · Class: 5.1%
- Mark Kingdon
Shares: 765,000.00 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-004068
- Form type
- SCHEDULE 13G
- Filer
- Jasper Therapeutics, Inc.
- CIK
- CIK 1788028
- Filed
- Jul 11, 2025
- Reporting period
- Jul 03, 2025
- Description
- Schedule 13G beneficial ownership